CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards
- 11 May 2010
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 11 (2) , 108-112
Abstract
Earlier we had found that the CYP2C9*2 allelic frequency was lower in Mexican-Americans living in California than in Spaniards (SP). This was assumed to be related to the low CYP2C9*2 and *3 allele frequencies in Orientals. This study was therefore aimed at analyzing whether there were also differences in CYP2C9 allele frequencies between Mexican-Tepehuanos (MT) and Mexican-Mestizos (MM) living in northwestern Mexico and SP. The CYP2C9*2 frequency was expected to be lower in the indigenous MT than in the two other groups, and lower in MM than in SP as in our earlier study. CYP2C9 genotypes and allele frequencies of two populations of healthy volunteers, MT (n=99) and MM (n=102), were compared with a population of SP (n=327). The data were also compared with our previously published population of Mestizo-Mexican-Americans (MA). The CYP2C9 genotypes among the studied populations were in equilibrium. The frequencies of CYP2C9*2 were 0.01, 0.07, 0.08, and 0.16 for MT, MM, MA, and SP subjects, respectively. In agreement with our hypothesis, CYP2C9*2 was significantly lower in the Mexican populations than in the SP (PPCYP2C9*3 was found to be lower (PCYP2C9*6 allele was present just in one MM subject, and CYP2C9*4 and *5 were not found in the studied populations. Therefore, these findings add further evidence about CYP2C9 genetic diversity within Hispanic populations with regard to their ancestry. Considering that CYP2C9*2 and CYP2C9*3 alleles have altered catalytic activities relative to CYP2C9*1, the present data suggest the need for pharmacogenetic studies to optimize drug dosages in different populations.Keywords
This publication has 15 references indexed in Scilit:
- Prevalence of CYP2C9 polymorphisms in the south of EuropeThe Pharmacogenomics Journal, 2009
- Prevalence of CYP2C9 Variants in the Mexican PopulationArchives of Medical Research, 2008
- CYP2D6Genotype and Phenotype in Amerindians of Tepehuano Origin and Mestizos of Durango, MexicoThe Journal of Clinical Pharmacology, 2006
- Lower frequency of CYP2C9*2 in Mexican-Americans compared to SpaniardsThe Pharmacogenomics Journal, 2004
- CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteersEuropean Journal of Clinical Pharmacology, 2003
- Clinical relevance of genetic polymorphisms in the human CYP2C subfamilyBritish Journal of Clinical Pharmacology, 2001
- Cytochrome P4502C9: an enzyme of major importance in human drug metabolismBritish Journal of Clinical Pharmacology, 1998
- Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and InhibitorsDrug Metabolism Reviews, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Biochemistry and molecular biology of the human CYP2C subfamilyPharmacogenetics, 1994